Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares traded up 1.8% on Thursday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares traded hands during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Price Performance
The company has a current ratio of 9.74, a quick ratio of 9.41 and a debt-to-equity ratio of 0.52. The company’s 50 day moving average is C$0.58 and its 200-day moving average is C$0.58. The stock has a market cap of C$25.87 million, a PE ratio of -1.07 and a beta of 1.22.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Read More
- Five stocks we like better than Acasti Pharma
- How to Choose Top Rated Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Best Stocks Under $5.00
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Invest in Blue Chip Stocks
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
